Pharmacokinetics and renal safety of tenofovir alafenamide with boosted protease inhibitors and ledipasvir/sofosbuvir.
Brooks KM, Castillo-Mancilla JR, Morrow M, MaWhinney S, Blum J, Wyles DL, Rowan SE, Ibrahim ME, Zheng JH, Johnson B, Gomez J, Choi YJ, Cendali F, Haas H, Roon L, Bushman LR, Anderson PL, Kiser JJ.
Brooks KM, et al. Among authors: ibrahim me.
J Antimicrob Chemother. 2020 Nov 1;75(11):3303-3310. doi: 10.1093/jac/dkaa299.
J Antimicrob Chemother. 2020.
PMID: 32766700
Free PMC article.